开云app官网登录入口网页版-官方正版

#Ⅲ期非小细胞肺癌#

4篇内容 | 981人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2211345, encodeId=4a4a2211345ec, content=<a href='/topic/show?id=1a5a58e00ad' target=_blank style='color:#2F92EE;'>#新辅助治疗#</a> <a href='/topic/show?id=4eac112112' target=_blank style='color:#2F92EE;'>#2期试验#</a> <a href='/topic/show?id=b874958164' target=_blank style='color:#2F92EE;'>#Ⅲ期非小细胞肺癌#</a>, objectTitle=CANCER CELL | 新辅助SHR-1701单药或联合化疗治疗无法切除的III期非小细胞肺癌：一项概念验证2期试验, objectType=article, longId=831530, objectId=6d0083153037, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719198858236_92910.png, objectUrl=/article/show_article.do?id=6d0083153037, replyNumber=0, likeNumber=91, createdTime=2024-06-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6d0083153037, moduleTitle=CANCER CELL | 新辅助SHR-1701单药或联合化疗治疗无法切除的III期非小细胞肺癌：一项概念验证2期试验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6d0083153037)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1985023, encodeId=f93c1985023aa, content=<a href='/topic/show?id=b874958164' target=_blank style='color:#2F92EE;'>#Ⅲ期非小细胞肺癌#</a>, objectTitle=Ⅲ期非小细胞肺癌的诊疗经验, objectType=article, longId=175799, objectId=84ff1e579925, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84ff1e579925, replyNumber=0, likeNumber=87, createdTime=2020-02-25, rootId=0, userName=ms6897892027066920, userId=b3812500089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84ff1e579925, moduleTitle=Ⅲ期非小细胞肺癌的诊疗经验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=84ff1e579925)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985021, encodeId=bf771985021db, content=<a href='/topic/show?id=b874958164' target=_blank style='color:#2F92EE;'>#Ⅲ期非小细胞肺癌#</a>, objectTitle=2019 多学科共识声明：Ⅲ期非小细胞肺癌患者的临床管理, objectType=article, longId=168422, objectId=323a16842219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=323a16842219, replyNumber=0, likeNumber=62, createdTime=2020-04-06, rootId=0, userName=ms6897892027066920, userId=b3812500089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=323a16842219, moduleTitle=2019 多学科共识声明：Ⅲ期非小细胞肺癌患者的临床管理, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=323a16842219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985022, encodeId=c43f1985022ac, content=<a href='/topic/show?id=b874958164' target=_blank style='color:#2F92EE;'>#Ⅲ期非小细胞肺癌#</a>, objectTitle=难得的“1+1＞2” ——记Ⅲ期非小细胞肺癌的放疗免疫联合之路, objectType=article, longId=175269, objectId=e0e61e52692f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0e61e52692f, replyNumber=0, likeNumber=69, createdTime=2019-12-11, rootId=0, userName=ms6897892027066920, userId=b3812500089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0e61e52692f, moduleTitle=难得的“1+1＞2” ——记Ⅲ期非小细胞肺癌的放疗免疫联合之路, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e0e61e52692f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985020, encodeId=cd6419850205c, content=<a href='/topic/show?id=b874958164' target=_blank style='color:#2F92EE;'>#Ⅲ期非小细胞肺癌#</a>, objectTitle=JCO：年龄对Ⅲ期非小细胞肺癌同步放化疗疗效的影响, objectType=article, longId=99161, objectId=c4f599161d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4f599161d1, replyNumber=0, likeNumber=72, createdTime=2017-09-01, rootId=0, userName=ms6897892027066920, userId=b3812500089, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4f599161d1, moduleTitle=JCO：年龄对Ⅲ期非小细胞肺癌同步放化疗疗效的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c4f599161d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

Ⅲ期非小细胞肺癌

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#新辅助治疗# #2期试验# #Ⅲ期非小细胞肺癌#

CANCER CELL | 新辅助SHR-1701单药或联合化疗治疗无法切除的III期非小细胞肺癌：一项概念验证2期试验

2024-06-24发表于上海

ms6897892027066920 (审核中...)

前往app查看评论内容

#Ⅲ期非小细胞肺癌#

Ⅲ期非小细胞肺癌的诊疗经验

2020-02-25

ms6897892027066920 (审核中...)

前往app查看评论内容

#Ⅲ期非小细胞肺癌#

2019 多学科共识声明：Ⅲ期非小细胞肺癌患者的临床管理

2020-04-06

ms6897892027066920 (审核中...)

前往app查看评论内容

#Ⅲ期非小细胞肺癌#

难得的“1+1＞2” ——记Ⅲ期非小细胞肺癌的放疗免疫联合之路

2019-12-11

ms6897892027066920 (审核中...)

前往app查看评论内容

#Ⅲ期非小细胞肺癌#

JCO：年龄对Ⅲ期非小细胞肺癌同步放化疗疗效的影响

2017-09-01

科室
- - 订阅+
  - 更多科室
工具
服务